Cleft palate, retrognathia and congenital heart disease in velo-cardio-facial syndrome: A phenotype correlation study

International Journal of Pediatric Otorhinolaryngology

Volumn 75, Issue 9, 2011, Pages 1167-1172

  Friedman, Marcia A ^a   Miletta, Nathanial ^a   Roe, Cheryl ^b   Wang, Dongliang ^b   Morrow, Bernice E ^c   Kates, Wendy R ^b   Higgins, Anne Marie ^a   Shprintzen, Robert J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

22q11 Deletion; Aortic arch anomalies; Cleft palate; Conotruncal heart anomalies; Occult submucous cleft palate; Retrognathia; Submucous cleft palate; TBX1; Tetralogy of Fallot; VCFS; Velo cardio facial syndrome

Indexed keywords

DNA; T BOX TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CAUCASIAN; CHROMOSOME 22Q; CLEFT PALATE; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL HEART DISEASE; DNA MICROARRAY; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; RETROGNATHIA; RETROSPECTIVE STUDY; VELOCARDIOFACIAL SYNDROME;

ABNORMALITIES, MULTIPLE; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 21; CLEFT PALATE; COHORT STUDIES; DIGEORGE SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; RETROGNATHISM; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES; YOUNG ADULT;

EID: 80051890270     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.06.013     Document Type: Article

References (40)

1. Shprintzen R.J., Goldberg R.B., Lewin M.L., et al. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J. 1978, 15(1):56-62.
2. Shprintzen R.J., Higgins A.M., Antshel K., Fremont W., Roizen N., Kates W. Velo-cardio-facial syndrome. Curr. Opin. Pediatr. 2005, 17(6):725-730.
3. Robin N.H., Shprintzen R.J. Defining the clinical spectrum of deletion 22q11.2. J. Pediatr. 2005, 147(1):90-96.
4. Morrow B., Goldberg R., Carlson C., et al. Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. Am. J. Hum. Genet. 1995, 56(6):1391-1403.
5. Carlson C., Sirotkin H., Pandita R., et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am. J. Hum. Genet. 1997, 61(3):620-629.
6. Edelmann L., Pandita R.K., Spiteri E., et al. A common molecular basis for rearrangement disorders on chromosome 22q11. Hum. Mol. Genet. 1999, 8(7):1157-1167.
7. Edelmann L., Pandita R.K., Morrow B.E. Low-copy repeats mediate the common 3-mb deletion in patients with velo-cardio-facial syndrome. Am. J. Hum. Genet. 1999, 64(4):1076-1086.
8. Shaikh T.H., Kurahashi H., Saitta S.C., et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum. Mol. Genet. 2000, 9(4):489-501.
9. Shprintzen R.J. Palatal and pharyngeal anomalies in craniofacial syndromes. Birth Defects Orig. Artic. Ser. 1982, 18(1):53-78.
10. Shprintzen R.J., Golding-Kushner K. Velo-Cardio-Facial Syndrome 2008, vol. 1. Plural Publishing, San Diego, CA.
11. Chapman D.L., Garvey N., Hancock S., et al. Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. Dev. Dyn. 1996, 206(4):379-390.
12. Jerome L.A., Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 2001, 27(3):286-291.
13. Lindsay E.A., Vitelli F., Su H., et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001, 410(6824):97-101.
14. Merscher S., Funke B., Epstein J.A., et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104(4):619-629.
15. Stalmans I., Lambrechts D., De Smet F., et al. VEGF: a modifier of the del22q11 (DiGeorge) syndrome?. Nat. Med. 2003, 9(2):173-182.
16. Vitelli F., Taddei I., Morishima M., Meyers E.N., Lindsay E.A., Baldini A. A genetic link between Tbx1 and fibroblast growth factor signaling. Development 2002, 129(19):4605-4611.
17. Cohen M.M. Robin sequences and complexes: causal heterogeneity and pathogenetic/phenotypic variability. Am. J. Med. Genet. 1999, 84(4):311-315.
18. Shprintzen R.J. The implications of the diagnosis of robin sequence. Cleft Palate Craniofac. J. 1992, 29(3):205-209.
19. Devriendt K., Moerman P., Van Schoubroeck D., Vandenberghe K., Fryns J.P. Chromosome 22q11 deletion presenting as the potter sequence. J. Med. Genet. 1997, 34(5):423-425.
20. Wraith J.E., Super M., Watson G.H., Phillips M. Velo-cardio-facial syndrome presenting as holoprosencephaly. Clin. Genet. 1985, 27(4):408-410.
21. Croft C.B., Shprintzen R.J., Daniller A., Lewin M.L. The occult submucous cleft palate and the musculus uvulae. Cleft Palate J. 1978, 15(2):150-154. accessed 12.08.10.
22. Chegar B.E., Tatum S.A., Marrinan E., Shprintzen R.J. Upper airway asymmetry in velo-cardio-facial syndrome. Int. J. Pediatr. Otorhinolaryngol. 2006, 70(8):1375-1381.
23. K.J. Preacher. Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence. (accessed 28.05.10). http://www.quantpsy.org/.
24. R.J. Shprintzen. VCFS educational foundation clinical database project. VCFS educational foundation. (accessed 28.05.10). http://www.vcfef.org/powerpoint/vcf_facts/index.htm.
25. Goldmuntz E., Clark B.J., Mitchell L.E., et al. Frequency of 22q11 deletions in patients with conotruncal defects. J. Am. Coll. Cardiol. 1998, 32(2):492-498.
26. Marino B., Digilio M.C., Toscano A., et al. Anatomic patterns of conotruncal defects associated with deletion 22q11. Genet. Med. 2001, 3(1):45-48.
27. Momma K. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am. J. Cardiol. 2010, 105(11):1617-1624.
28. Geis N., Seto B., Bartoshesky L., Lewis M.B., Pashayan H.M. The prevalence of congenital heart disease among the population of a metropolitan cleft lip and palate clinic. Cleft Palate J. 1981, 18(1):19-23.
29. Shprintzen R.J., Siegel-Sadewitz V.L., Amato J., Goldberg R.B. Anomalies associated with cleft lip, cleft palate, or both. Am. J. Med. Genet. 1985, 20(4):585-595.
30. Ferencz C., Rubin J.D., McCarter R.J., et al. Congenital heart disease: prevalence at livebirth. The baltimore-washington infant study. Am. J. Epidemiol. 1985, 121(1):31-36.
31. M. Vazquez. Cleft palate. Orphanet. (accessed 13.08.10). http://www.orpha.net/consor/cgi-bin/OC_Exp.php%3Flng=EN%26Expert=2014.
32. Lipson A.H., Yuille D., Angel M., Thompson P.G., Vandervoord J.G., Beckenham E.J. Velocardiofacial (shprintzen) syndrome: an important syndrome for the dysmorphologist to recognise. J. Med. Genet. 1991, 28(9):596-604.
33. Liao J., Kochilas L., Nowotschin S., et al. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum. Mol. Genet. 2004, 13(15):1577-1585.
34. Arnold J.S., Werling U., Braunstein E.M., et al. Inactivation of Tbx1 in the pharyngeal endoderm results in 22q11DS malformations. Development 2006, 133(5):977-987.
35. Arvystas M., Shprintzen R.J. Craniofacial morphology in the velo-cardio-facial syndrome. J. Craniofac. Genet. Dev. Biol. 1984, 4(1):39-45.
36. Shprintzen R.J. Pierre robin, micrognathia, and airway obstruction: the dependency of treatment on accurate diagnosis. Int. Anesthesiol. Clin. 1988, 26(1):64-71.
37. Sher A.E., Shprintzen R.J., Thorpy M.J. Endoscopic observations of obstructive sleep apnea in children with anomalous upper airways: predictive and therapeutic value. Int. J. Pediatr. Otorhinolaryngol. 1986, 11(2):135-146.
38. Sher A.E. Mechanisms of airway obstruction in robin sequence: implications for treatment. Cleft Palate Craniofac. J. 1992, 29(3):224-231.
39. Derbent M., Yilmaz Z., Baltaci V., Saygili A., Varan B., Tokel K. Chromosome 22q11.2 deletion and phenotypic features in 30 patients with conotruncal heart defects. Am. J. Med. Genet. A 2003, 116A(2):129-135.
40. Zim S., Schelper R., Kellman R., Tatum S., Ploutz-Snyder R., Shprintzen R. Thickness and histologic and histochemical properties of the superior pharyngeal constrictor muscle in velocardiofacial syndrome. Arch. Facial Plast. Surg. 2003, 5(6):503-510.